Profiling trial burden and patients’ attitudes to improve clinical research in epidermolysis bullosa

BACKGROUND: Epidermolysis bullosa (EB) comprises inherited mechanobullous dermatoses with considerable morbidity and mortality. While current treatments are symptomatic, a growing number of innovative therapeutic compounds are evaluated in clinical trials. Clinical research in rare diseases like EB,...

Descripción completa

Detalles Bibliográficos
Autores principales: Prodinger, Christine, Diem, Anja, Ude-Schoder, Katherina, Piñón-Hofbauer, Josefina, Kitzmueller, Sophie, Bauer, Johann W., Laimer, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350741/
https://www.ncbi.nlm.nih.gov/pubmed/32650809
http://dx.doi.org/10.1186/s13023-020-01443-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350741/
https://www.ncbi.nlm.nih.gov/pubmed/32650809
http://dx.doi.org/10.1186/s13023-020-01443-3

Ejemplares similares